NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options (Q36384721)

13 August 2017

1 reference

title

NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options (English)

1 reference

13 August 2017

0 references

Jørgen Naesdal

1

1 reference

PubMed ID

16454539

13 August 2017

Kurt Brown

series ordinal

2

1 reference

13 August 2017

1 January 2006

1 reference

13 August 2017

1 reference

13 August 2017

29

1 reference

13 August 2017

2

1 reference

13 August 2017

119-132

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200629020-00002

13 August 2017

0 references

cites work

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629020-00002

Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629020-00002

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629020-00002

The effectiveness of ranitidine in reducing gastric acid-secretion decreases with continued therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629020-00002

Parecoxib, valdecoxib, and cardiovascular risk

21 January 2018

1 reference

12 December 2020

Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study

1 reference

12 December 2020

Cyclooxygenases: structural, cellular, and molecular biology

1 reference

12 December 2020

Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine

1 reference

12 December 2020

Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis

1 reference

12 December 2020

Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis

1 reference

12 December 2020

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

12 December 2020

Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study

1 reference

12 December 2020

Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens

1 reference

12 December 2020

Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration

1 reference

12 December 2020

Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis

1 reference

12 December 2020

Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac

1 reference

12 December 2020

Toxicity of nonsteroidal anti-inflammatory drugs. An overview of the epidemiological evidence.

1 reference

12 December 2020

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

1 reference

12 December 2020

Parecoxib sodium demonstrates gastrointestinal safety comparable to placebo in healthy subjects

1 reference

12 December 2020

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

1 reference

12 December 2020

The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis

1 reference

12 December 2020

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

12 December 2020

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models

1 reference

12 December 2020

Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs.

1 reference

12 December 2020

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

1 reference

12 December 2020

Effect of indomethacin on gastric acid and bicarbonate secretion in humans

1 reference

12 December 2020

Endoscopy in asymptomatic minidose aspirin consumers

1 reference

12 December 2020

Clinical pharmacology of novel selective COX-2 inhibitors

1 reference

12 December 2020

Epidemiology of digestive complications associated with use of low-dose aspirin

1 reference

12 December 2020

Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drug gastropathy

1 reference

12 December 2020

Gastroduodenal mucosal protection

1 reference

12 December 2020

Coxibs and cardiovascular disease

1 reference

12 December 2020

Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis

1 reference

12 December 2020

Gastroduodenal safety and tolerability of lumiracoxib compared with Ibuprofen and celecoxib in patients with osteoarthritis.

1 reference

12 December 2020

Prevention of the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: the role of proton pump inhibitors

1 reference

12 December 2020

NSAID induced gastrointestinal complications: the ARAMIS perspective--1997. Arthritis, Rheumatism, and Aging Medical Information System.

1 reference

12 December 2020

Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration.

1 reference

12 December 2020

Epidemiology of NSAID induced gastrointestinal complications.

1 reference

12 December 2020

Do NSAIDs cause dyspepsia? A meta-analysis evaluating alternative dyspepsia definitions

1 reference

12 December 2020

ABC of the upper gastrointestinal tract: Indigestion and non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs

1 reference

12 December 2020

Cost of treating arthritis and NSAID-related gastrointestinal side-effects

1 reference

12 December 2020

Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease

1 reference

12 December 2020

Gastrointestinal injury from NSAID therapy. How to reduce the risk of complications

1 reference

12 December 2020

Recent considerations in nonsteroidal anti-inflammatory drug gastropathy

1 reference

12 December 2020

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

1 reference

12 December 2020

Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH.

1 reference

12 December 2020

An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates

1 reference

12 December 2020

Effect of indomethacin on basal and histamine stimulated human gastric acid secretion

1 reference

12 December 2020

Platelet-active drugs : the relationships among dose, effectiveness, and side effects

1 reference

12 December 2020

Factors affecting over-the-counter use of aspirin in the secondary prophylaxis of cardiovascular disease

1 reference

12 December 2020

Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use

1 reference

12 December 2020

Platelet activation in unstable coronary disease

1 reference

12 December 2020

The mucoid cap over superficial gastric damage in the rat. A high-pH microenvironment dissipated by nonsteroidal antiinflammatory drugs and endothelin

1 reference

12 December 2020

NSAID gastric ulceration: predictive value of gastric pH, mucosal density of polymorphonuclear leukocytes, or levels of IL-8 or nitrite.

1 reference

12 December 2020

Doubt and certainty about nonsteroidal anti-inflammatory drugs in the year 2000: a multidisciplinary expert statement

1 reference

12 December 2020

Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs

1 reference

12 December 2020

The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from a randomized, controlled trial.

1 reference

12 December 2020

Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis

1 reference

12 December 2020

Use and benefits of nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020

Effect of one-month treatment with nonsteroidal antiinflammatory drugs (NSAIDs) on gastric pH of rheumatoid arthritis patients

1 reference

12 December 2020

Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group

1 reference

12 December 2020

New insights into the mode of action of anti-inflammatory drugs.

1 reference

12 December 2020

Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drug prescribing: past, present, and future

1 reference

12 December 2020

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

12 December 2020

Efficacy of 12 months' misoprostol as prophylaxis against NSAID-induced gastric ulcers. A placebo-controlled trial

1 reference

12 December 2020

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

12 December 2020

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

12 December 2020

Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs

1 reference

12 December 2020

Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.

1 reference

12 December 2020

Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis.

1 reference

12 December 2020

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

1 reference

12 December 2020

Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib

1 reference

12 December 2020

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

1 reference

12 December 2020

Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies

1 reference

12 December 2020

Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach

1 reference

12 December 2020

Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers

1 reference

12 December 2020

Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial

1 reference

12 December 2020

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy M

1 reference

12 December 2020

NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2

1 reference

12 December 2020

Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Effect of daily oral omeprazole on 24 hour intragastric acidity

1 reference

12 December 2020

The role of extracellular mucus as a protective cap over gastric mucosal damage.

1 reference

12 December 2020

Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor.

1 reference

12 December 2020

Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

1 reference

12 December 2020

Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs

1 reference

12 December 2020

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

12 December 2020

Nonsteroidal antiinflammatory drugs--differences and similarities

1 reference

12 December 2020

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

12 December 2020

The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events

1 reference

12 December 2020

10.2165/00002018-200629020-00002

Identifiers

DOI

1 reference

PubMed ID

16454539

Dimensions Publication ID

13 August 2017

0 references

1 reference

PubMed ID

16454539